Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today released its latest Scientific Update for Smoke-Free Products, a regular publication on its research efforts to develop and assess a range of smoke-free alternatives to cigarettes. The latest issue of the Scientific Update can be found at this link.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005891/en/
Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program (Photo: Business Wire)
This issue of the Scientific Update provides a closer look at some of the principles and practices on which PMI’s scientific assessment program is built. Director Medical Affairs Dr. Patrick Picavet describes specific examples from PMI’s clinical program that highlight the company’s commitment to the implementation of best practices, transparent research and the well-being of clinical trial participants.
Picavet stated, “The performance of clinical studies is a complicated process. Strict implementation of Good Clinical Practices is particularly important to assure the quality and consistency of the research and to address unexpected events that can occur during a study. These Practices are key to the validity of data and the safety of study participants.”
Beyond recent events and publications, this issue also describes PMI’s progress towards sharing all raw data from studies on IQOS in part through the new data-sharing platform called INTERVALS.
Prof. Manuel Peitsch, PMI’s Chief Scientific Officer, elaborates: “PMI is committed to openly sharing the research behind our smoke-free products. That’s why we are using our latest Scientific Update to explain the rigor behind our clinical program. We are going further by gradually making the data and results from the non-clinical and clinical program around our leading smoke-free product, IQOS, available to the public by early 2018.”
PMI’s extensive research and assessment program is inspired by the well-recognized practices of the pharmaceutical industry and in line with the draft guidance of the U.S. FDA for Modified Risk Tobacco Product (MRTP) Applications. PMI employs over 400 world-class scientists, engineers and experts who conduct rigorous research, including laboratory and clinical studies, as well as ground-breaking systems toxicology. The assessment program also includes studies on actual product use and correct understanding of product communications, as well as post-market research.
About Philip Morris International Inc. (“PMI”)
Philip Morris International Inc. (PMI) is a leading international tobacco company, with six of the world's top 15 international brands and products sold in more than 180 markets. In addition to the manufacture and sale of cigarettes, including Marlboro, the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of reduced-risk products (RRPs). RRPs is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and industry-leading scientific substantiation, PMI aims to provide an RRP portfolio that meets a broad spectrum of adult smoker preferences and rigorous regulatory requirements. For more information, see our PMI and PMI Science websites.
Philip Morris International media office
T: +41 (0)58 242 4500
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Schneider Electric Selects DSI for a Full Mobile Work Order Solution24.4.2018 11:21 | Tiedote
DSI announced today that Schneider Electric has selected DSI to mobilize their services organization with a mobile work order and inventory solution fully integrated into NetSuite. The Solar Business of Schneider Electric is focused on designing and developing products and solutions for the solar power conversion chain and providing best-in-class global customer services and technical support. As the solar market goes through a rapid wave of consolidations, Schneider Electric is one of the few companies that remains committed in its efforts to provide spare parts, service and technical support over the 20+ year life of a solar installation. To maintain their position as an industry leader, Schneider sought a mobile service application with on and offline capabilities to operate across their global network of engineers. They needed a solution to allow supervisors to schedule and assign service orders to the most appropriate resources and for engineers to have full visibility of customer
Vertex Announces Partnership and Integration with SAP® Ariba® to Support Global Tax Functionality24.4.2018 10:53 | Tiedote
Vertex, Inc., a leading provider of tax technology solutions, announced its partnership with SAP® Ariba®, including the availability of an integration between its indirect tax solutions and SAP Ariba applications. Vertex is among the first to offer an extension leveraging an SAP Ariba API to enable companies to obtain tax calculations from within SAP Ariba solutions, supporting the requisition and invoice reconciliation phases of the tax process. “As businesses strive to manage the impact of digital transformation and increased tax complexity, Vertex has prioritized developing integrations that serve the global tax community’s needs on the tools they already use. This partnership with SAP Ariba will drive users’ success by providing enterprise-ready tax functionality,” said Paul Beirnes, managing director of partner development at Vertex. SAP Ariba solutions integrate the entire buying process across an organization. These solutions connect to millions of suppliers across direct and in
Sofinnova Partners Leads EryDel’s €26.5 Million Financing24.4.2018 09:00 | Tiedote
Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, announced today it has led EryDel’s €26.5 M financing. The Italian biotech company, which specializes in drug delivery through red blood cells, will be using funds to boost its international development and to complete the ATTEST trial - a registrational Phase III clinical trial currently enrolling in Europe, Asia, Australia and in the United States. Next to Sofinnova Partners, existing shareholder Genextra SpA and Innogest SGR also participated to the investment. Based in Milan (Italy), EryDel develops an innovative red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Its proprietary technology relies upon the encapsulation of drugs into red cells taken from the patient’s own blood which are then re-infused into the patient. The company is led by Luca Benatti, CEO, a serial entrepreneur who previously co-founded Newron Pharmaceuticals (NWRN). EryDel’s le
Culture Trip Raises $80M in Large Series B Funding Round24.4.2018 08:05 | Tiedote
Culture Trip, the fast-growing startup providing cultural and travel inspiration to users looking to explore the world, today announced $80M in funding. This large series B investment further demonstrates that Silicon Valley-sized startup deals are continuing in Europe. Led by PPF Group, the round is being used to aggressively propel the business forward across all areas, including an immediate bolstering of its executive team with key hires joining from leading tech companies, and a product redesign launching today. Off the back of the raise, Culture Trip will also use the funds to significantly expand its engineering and creative workforce around the world to fuel innovation, drive further audience growth and roll out various monetisation strategies. “I started Culture Trip with the ambition of applying my long-standing passion for global culture and creativity to building a tech company that could innovate in this space,” said Dr. Kris Naudts, Founder and CEO of Culture Trip. “With
First-Quarter Figures: Sartorius Starts off Fiscal 2018 Successfully24.4.2018 08:00 | Tiedote
Sartorius, a leading international partner of the biopharmaceutical industry and the research sector, looks back on a successful first quarter 2018. "Both divisions started off the year strongly in line with our expectations and further increased their revenues in the first quarter of 2018 in all regions. On the currency side, however, we faced some headwinds, especially due to the weakness of the U.S. dollar against the euro, which dampened our profit growth. Order intake developed at an encouragingly strong level for both divisions so we look optimistically to the months ahead and confirm our full-year forecast," said CEO Dr. Joachim Kreuzburg. Business development of the Sartorius Group In the first quarter of 2018, Sartorius increased its sales revenue by 11.4% (reported: 6.3%) in constant currencies to 364.9 million euros, with acquisitions contributing around 4.5 percentage points to this growth. Order intake for the same period rose 12.4%. Regionally, Asia|Pacific recorded the s
The Digital Classroom: Gemalto Helps Casio to Bring Education into the 21st Century24.4.2018 08:00 | Tiedote
Gemalto, the world leader in digital security, can today reveal that it has partnered with Casio, one of the world’s leading manufacturers of consumer electronics products and business equipment solutions, to enable Casio to seamlessly bring digital education into the classroom and beyond. This move will help Casio continue its leadership in classroom technology, fuelled by trends including increased use of connected devices, remote learning and the gamification of education, at the same time maximising revenues and streamlining business operations. With the implementation of Gemalto Sentinel Entitlement Management System (EMS) and software license Rights Management System (RMS) solutions, Casio will have an enhanced understanding of how their software features are being used in the classroom. Founded in 1957, Casio released the world’s first personal calculator and has gone on to produce a variety of products including calculators, watches, electronic dictionaries, electronic musical
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme